ADORA2A and neoplasm: More recently, targeting A2AR via both A2AR inhibition or in A2AR-deficient mice resulted in improved tumor control and inhibition of tumor progression through elimination of the A2AR-induced suppression of NK cell maturation by promoting the accumulation of highly cytotoxic CD56dim NK cells (84).